ORIGINAL RESEARCH
Published on 29 Jun 2022
Identification of Novel Tumor Microenvironment Regulating Factor That Facilitates Tumor Immune Infiltration in Cervical Cancer
doi 10.3389/fonc.2022.846786
- 1,489 views
- 3 citations
- Frontiers in Oncology
- Gynecological Oncology
- Research Topics
- Tumor Microenvironment and Therapeutic Resistance in Gynecologic Malignancies
Tumor Microenvironment and Therapeutic Resistance in Gynecologic Malignancies
10k
Total downloads
32k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 24 Jun 2022
Transcriptome Analysis Reveals the Immune Infiltration Profiles in Cervical Cancer and Identifies KRT23 as an Immunotherapeutic Target
doi 10.3389/fonc.2022.779356
- 1,836 views
- 5 citations
ORIGINAL RESEARCH
Published on 10 May 2022
lncRNA-LET Regulates Glycolysis and Glutamine Decomposition of Esophageal Squamous Cell Carcinoma Through miR-93-5p/miR-106b-5p/SOCS4
doi 10.3389/fonc.2022.897751
- 1,284 views
- 7 citations
ORIGINAL RESEARCH
Published on 29 Apr 2022
Low-Intensity Focused Ultrasound Targeted Microbubble Destruction Enhanced Paclitaxel Sensitivity by Decreasing Autophagy in Paclitaxel-Resistant Ovarian Cancer
doi 10.3389/fonc.2022.823956
- 1,748 views
- 5 citations
ORIGINAL RESEARCH
Published on 29 Apr 2022
Survival Impacts of Perineural Invasion on Patients Under Different Radical Hysterectomies Due to Early Cervical Cancer
doi 10.3389/fonc.2022.889862
- 1,522 views
- 4 citations
ORIGINAL RESEARCH
Published on 22 Apr 2022
A Preliminary Exploration Using Imaging Methods to Predict the Possibility of the Recurrence of Serous Ovarian Cancer in Patients Undergoing Total Resection
doi 10.3389/fonc.2022.754067
- 894 views
METHODS
Published on 23 Mar 2022
Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study
doi 10.3389/fonc.2022.852772
- 3,333 views
- 10 citations
ORIGINAL RESEARCH
Published on 03 Mar 2022
CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
doi 10.3389/fonc.2022.798680
- 2,259 views
- 11 citations
CORRECTION
Published on 04 Feb 2022
Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein
doi 10.3389/fonc.2022.853608
- 709 views
ORIGINAL RESEARCH
Published on 13 Dec 2021
Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
doi 10.3389/fonc.2021.749144
- 2,855 views
- 9 citations
SYSTEMATIC REVIEW
Published on 28 Oct 2021
Prognostic Role of the C-Reactive Protein/Albumin Ratio in Patients With Gynecological Cancers: A Meta-Analysis
doi 10.3389/fonc.2021.737155
- 1,962 views
- 12 citations
ORIGINAL RESEARCH
Published on 21 Oct 2021
Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein
doi 10.3389/fonc.2021.752127
- 5,607 views
- 15 citations
Published in
Frontiers in Oncology
- Gynecological Oncology
Impact
- 32kTopic views
- 20kArticle views
- 10kArticle downloads